INTRODUCTION
Peroxisome proliferator-activated receptor δ is broadly expressed in several tissues (Amri et al., 1995) . Peroxisome proliferator-activated receptor δ plays a multifunctional role in lipid metabolism; namely, it increases lipolysis in adipose tissues (Wang et al., 2003) and fatty acid oxidation in the skeletal muscle (Kramer et al., 2007) .
For activation of PPARδ, a ligand is needed for binding to the ligand-binding domain. Several synthetic compounds, such as benzafibrate and L165041, have high binding affinity for PPARδ (Krey et al., 1997; Willson et al., 2000) . Fatty acids and fatty acid derivatives have been proposed to be possible endogenous ligands for PPARδ (Krey et al., 1997) . Arachidonate metabolites, prostacyclins, are capable of activating PPARδ (Lim et al., 1999) . Polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), activate PPARδ (Yu et al., 1995) . These results indicate that PUFA and PUFA metabolites are able to regulate PPARδ activity. It has been demonstrated that PUFA regulates hepatic lipid metabolism through activation of PPARα (Clarke and Jump, 1996) and increases insulin sensitivity by a PPARγ-dependent pathway (Neschen et al., 2006) . It is unclear whether PUFA has a role in interacting with PPARδ in adipose tissues to regulate lipid metabolism.
There is no in vivo evidence demonstrating the interaction of dietary PUFA with porcine PPARδ. Using stably transformed cells, we demonstrated that porcine PPARγ and PPARδ regulate lipid metabolism (Yu et al., 2006 (Yu et al., , 2008b and that DHA or its metabolites are able to activate porcine PPARγ (Yu et al., 2008a ). In the current study, we generated transgenic mice with adipose tissue-specific expression of porcine PPARδ to 
MATERIALS AND METHODS
The animal protocol was approved by the Animal Care and Use Committee of the National Taiwan University.
Generation of Transgenic Mice
To obtain the adipose tissue-specific expression of porcine PPARδ, porcine PPARδ cDNA was placed downstream of the mouse 5.4-kb adipocyte fatty acid-binding protein (aP2) promoter/enhancer and upstream of SV40 polyadenylation sequences ( Figure 1A ). It has been demonstrated that this promoter sequence is functional and regulated by adipocyte-specific transcription factors (Ross et al., 1990) . The porcine PPARδ sequence with SV40 polyadenylation sequences was successfully cloned in previous studies (Yu et al., 2008b) . Transgenic mice were generated by microinjection of the transgene into pronuclei of fertilized FVB/NJ mouse embryos. Founder genomic DNA was extracted and the presence of PPARδ was confirmed by PCR and Southern blot techniques. Southern blots were prepared following a standard protocol (Southern, 1975) . Adipose tissue PPARδ protein from transgenic mice was also identified by standard Western blot with modifications by Ding et al. (2002) . The anti-PPARδ polyclonal antibody (sc-1986, Santa Cruz Biotechnology Inc., Santa Cruz, CA) was used to determine the expression of transgene. Positive transgenic progeny were backcrossed with FVB/NJ mouse to generate homogenous transgenic mice. Transgenic mice from the F 3 generation were used in this study.
Animal Experiments
In the diet study, wild-type (FVB/NJ) and PPARδ transgenic mice were age-(7 to 8 wk old) and sexmatched. Both sexes of mice were used because there was no reported sex difference in PPARδ function in mammals. Wild-type mice and transgenic mice were each divided into 4 diet groups. Because animal death is expected in a long-term feeding experiments, more Porcine peroxisome proliferator-activated receptor δ was regulated by adipocyte fatty acid-binding protein (aP2) promoter/enhancer. B: Southern blot analysis of aP2 promoter/enhancer-PPARδ transgenic mice (PPARδ TG). For detection of transgene insertion, tail genomic DNA from wild-type mice (WT) and PPARδ transgenic mice were digested with KpnI and separated on agarose gel. After enzyme digestion, the transgene generated 1.4 kb of PPARδ fragment. The blots were hybridized with a porcine PPARδ cDNA probe. C: Western blot analysis of PPARδ transgenic mice. For confirmation of protein production in PPARδ transgenic mice, total proteins from the adipose tissue were separated, blotted, and hybridized with a PPARδ antibody. β-Actin was an indicator of equivalent protein loading. The detection of the transgene and the protein was performed in 3 individual mice, all yielding the same result.
than enough animals were assigned to each treatment (between 10 and 14 in each group). Mice were provided feed for ad libitum consumption. The first group was fed a standard diet that contained, on a caloric basis, 58% carbohydrate, 13.5% fat, and 28.5% protein (LabDiet 5001, LabDiet, Richmond, IN). The second group was fed the standard diet containing L165041 at a concentration of 4 mg/kg (Cayman Chemicals, Ann Arbor, MI); on a caloric basis, it contained 58% carbohydrate, 13.5% fat, and 28.5% protein (Bioserv, Frenchtown, NJ) . The dose of L165041 was chosen because similar treatments were demonstrated to be effective by others (Oliver et al., 2001; Shan et al., 2008) . The third group was fed a high-fish oil (mainly from tuna) diet; on a caloric basis, it contained 36% carbohydrate, 35.5% fat, and 28.5% protein (Bioserv, Frenchtown, NJ). The fourth group was fed a high-beef tallow diet; on a caloric basis, it contained 36% carbohydrate, 35.5% fat, and 28.5% protein (Bioserv, Frenchtown, NJ). Mice were fed the experimental diets for 4 mo. Feed intake was determined monthly. At the end of dietary treatments, mice were weighed and killed by cervical dislocation after anesthesia using tribromoethanol, (0.4 mg/g of BW, intraperitoneal; Sigma, St. Louis, MO). Fat pads (male: epididymal fat pads; female: ovarian fat pads) were isolated immediately and weighed. The liver (right lobe) and white adipose tissue were fixed for histochemical staining or frozen in liquid nitrogen for RNA extraction.
Biochemical Assays
A blood sample of 0.3 mL was obtained from the tail of each mouse at the end of dietary treatments. Blood plasma was isolated by centrifuging blood samples treated with EDTA as an anticoagulant at 2,000 × g for 20 min at 4°C and used to colorimetrically measure glucose (K606-100, kits from BioVision Inc., Mountain View, CA), triacyglycerol (K622-100, kits from BioVision Inc.), and FFA (K612-100, kits from BioVision Inc.). Plasma adiponectin (ADN) was measured using a mouse ELISA kit (B-Bridge International Inc., Mountain View, CA).
Histochemistry
Tissues were fixed in 10% formalin and embedded in paraffin. Sections (4 μm thick) were cut and stained with hematoxylin/eosin staining. For Oil Red O staining, tissues were embedded in optimal cutting temperature medium and cryosectioned following a standard protocol with modifications by Wang et al. (2006) . Frozen sections were subjected to standard Oil Red O staining (Koopman et al., 2001 ).
Quantitative Real-Time PCR
Tissue RNA of 3 mice randomly selected from each treatment was extracted using TRIzol (Invitrogen, Carlsbad, CA). Reverse transcription was performed with the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems Inc., Foster City, CA). Real-time PCR was performed to quantify the mRNA concentration of each gene using the LightCycler 480 Instrument II (Roche Diagnostics, Indianapolis, IN) and the RealQ-PCR Master Mix Kit (Ampliqon, Herlev, Denmark). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA concentration was also determined and served as the internal control. The sequence of primers for quantitative reverse transcription-PCR is listed in Table 1 . The mRNA expression of each gene was normalized to its GAPDH mRNA. Threshold cycle (Ct) values were obtained and relative gene expression was calculated using the formula (1/2) Ct target genes − Ct GAPDH (Schmittgen et al., 2000) as described by Chen et al. (2008) .
Statistical Analysis
The treatment effects were analyzed using an ANO-VA procedure to determine the main effects of PPARδ and diets. Statistical analysis of results was performed by a 2 × 4 factorial arrangement of treatments (mice background and diet treatments); Duncan's new multiple range test was used to evaluate differences among means (SAS Inst. Inc., Cary, NC). A significant difference indicates that P-value is not greater than 0.05.
RESULTS

Expression of Porcine PPARδ in Transgenic Mice
Successful integration of the transgene was confirmed by Southern blot ( Figure 1B ). Endogenous PPARδ protein expression was decreased in wild-type mice (Figure 1C) , whereas the transgenic mice carrying porcine PPARδ had increased PPARδ protein expression in the adipose tissue ( Figure 1C ).
The Effect of Dietary Fatty Acids on the Phenotype of Transgenic Mice
Dietary treatments affected feed intake (P < 0.01), BW (P < 0.01), and fat pad weights (P < 0.01, Figure 2) . The mouse genetic backgrounds (wild-type vs. transgenic) had no effect on feed intake (P > 0.05) but had an effect on BW (P < 0.01) and fat pad weights (P < 0.01). In wild type and transgenic mice, mice fed the PPARδ ligand, L165041, or either of the high-fat diets had reduced (P < 0.05) feed intake ( Figure 2A ). The terminal BW was decreased (P < 0.05) in fish oil-fed mice of either genotype and in transgenic mice fed the PPARδ ligand ( Figure 2B ). Fat pad weight was dramatically decreased (P < 0.05) in fish oil-fed mice of either genotype; the decrease was greater in transgenic mice ( Figure 2C ). Beef tallow feeding increased (P < 0.05) fat pad weight in wild type, but not in transgenic mice, whereas feeding the PPARδ ligand decreased (P < 0.05) fat pad weight in transgenic, but not in wildtype mice.
Both diet treatment and genetic background had effects on plasma triacylglycerol and plasma FFA. Fish oil feeding reduced (P < 0.05) plasma triacylglycerol, particularly in the PPARδ transgenic mice ( Figure 3A) . Feeding of the PPARδ-ligand, L165041 also decreased (P < 0.05) plasma triacylglycerol in transgenic mice, but the effect was less than with fish oil feeding ( Figure  3A ). Transgenic mice had less (P < 0.05) plasma FFA concentration than wild-type mice when fed each of the diets ( Figure 3B ). In both genotypes, feeding the PPARδ ligand reduced (P < 0.05) the FFA concentration and feeding fish oil decreased the concentration to an even greater extent. Dietary beef tallow increased (P < 0.05) the FFA concentration in wild-type mice. Genetic backgrounds had an effect on plasma glucose Means without a common letter differ, P ≤ 0.05. concentration (P < 0.01). Dietary treatments had no effect on plasma glucose concentration (P > 0.05). Dietary fish oil treatments significantly increased the plasma ADN concentration (P < 0.01). The transgene did not affect the ADN secretion (P > 0.05). Plasma glucose concentration of PPARδ transgenic mice generally was less (P < 0.05) than wild-type mice across all dietary treatments ( Figure 3C ). Glucose concentration was increased (P < 0.05) in beef tallow-fed wild-type mice. Plasma ADN concentrations were increased (P < 0.05) by the fish oil treatment in both genotypes ( Figure 3D ).
Compared with wild-type mice, PPARδ transgenic mice fed L165041 had a smaller adipocyte size ( Figure  4 ). Fish oil feeding markedly decreased adipocyte size in wild-type mice, and size was further decreased in transgenic mice. Increased adipocyte size was observed wild-type mice fed a beef tallow diet ( Figure 4) ; transgenic mice had smaller adipocytes than wild-type mice when fed beef tallow. There was no lipid droplet accumulation in hepatocytes from wild-type mice or PPARδ transgenic mice fed the standard or L165041 diets (Figure 5 ). Feeding wild type or transgenic mice a fish oil diet slightly increased hepatic lipid droplet accumulation ( Figure 5) . A severe fatty liver was observed in wild-type mice fed beef tallow. Transgenic mice fed beef tallow had considerable hepatic fat deposition, but it was much less than that in wild-type mice.
Adipocyte-Specific PPARδ Overexpression Regulated the Expression of Genes Involved in Lipid Metabolism
Feeding the PPARδ ligand L165041 decreased (P < 0.05) lipoprotein lipase (LPL), aP2, and sterol regulatory element-binding protein 1c (SREBP-1c) mRNA concentrations ( Figure 6A , 6B, and 6D) in transgenic mice. The fish oil-fed transgenic mice also had less (P < 0.05) expression of adipogenic genes including LPL, aP2, ADN, and SREBP-1c ( Figure 6A to 6D ). In contrast, fish oil feeding increased (P < 0.05) LPL and aP2 mRNA concentrations in wild-type mice ( Figure  6A and B). Beef tallow feeding increased (P < 0.05) LPL, aP2, and SREBP-1c mRNA concentrations in both genotypes ( Figure 6A , 6B, and 6D). The mRNA concentration for uncoupling protein 3 (UCP-3) was increased (P < 0.05) in both genotypes by feeding the PPARδ ligand and in transgenic mice fed fish oil (Figure 6E) . The fish oil-fed PPARδ transgenic mice also had a greater (P < 0.05) mRNA concentration of hormone-sensitive lipase (HSL) when compared with the wild-type mice ( Figure 6F ). The interaction of the 2 major factors on the expression of LPL, aP2, SREBP1c, ADN, UCP-3, and HSL mRNA was significant (P < 0.05), indicating that the regulation of these genes by PPARδ transgene depended on the dietary treatments. In mice fed each diet, the liver β-oxidation genes, including acyl-CoA oxidase (ACO), carnitine palmitoyltransferase 1 (CPT-1), and long-chain acyl-CoA dehydrogenase (LCAD) generally were greater (P < 0.05) in transgenic compared with wild-type mice ( Figure  7A , 7B, and 7D). Feeding the PPARδ ligand, L165041 increased (P < 0.05) the CPT-1 expression in transgenic mice ( Figure 7B ). Dietary fish oil increased (P < 0.05) the mRNA concentration of ACO and mediumchain acyl-CoA dehydrogenase (MCAD) in wild-type mice ( Figure 7A and 7C ) and of ACO, CPT-1, MCAD, and LCAD in transgenic mice ( Figure 7A through 7D) . Feeding beef tallow increased (P < 0.05) the mRNA concentrations for ACO and CPT-1 in transgenic mice ( Figure 7A and 7B) . The mRNA for the hepatic lipogenic transcription factor, SREBP-1c, was decreased (P < 0.05) by fish oil feeding in both genotypes and was increased in wild-type mice when fed beef tallow ( Figure 7E ). The mRNA for the lipogenic gene, acetylCoA carboxylase, was increased (P < 0.05) by fish oil feeding and more so by beef tallow feeding in both genotypes ( Figure 7F ). Dietary treatments and genetic backgrounds interacted to affect ACO and CPT-1 mRNA expression (P < 0.05), indicating that the effect of PPARδ transgene on the expression of these genes also depends on which diet was fed.
DISCUSSION
Dietary fish oil, especially EPA and DHA, inhibits hepatic lipogenesis by suppression of SREBP-1c expression and promotes hepatic fatty acid oxidation by activation of PPARα (Clarke and Jump, 1996; Kim et al., 1999) . Experiments using PPARα knockout mice (Dallongeville et al., 2001 ) indicate that PPARα is required for dietary fish oil to induce hepatic genes involved in β-oxidation. These results demonstrate that fish oil regulates hepatic lipid metabolism mainly through activation of PPARα. However, fish oil not only affects lipid metabolism in the liver, it also regulates lipid metabolism in several peripheral tissues, especially in the adipose tissues (Nakatani et al., 2003) .
In the current studies, fish oil feeding significantly reduced BW and fat mass compared with dietary beef tallow treatment in wild-type mice. These results are consistent with previous studies (Belzung et al., 1993; Couet et al., 1997; Nakatani et al., 2003) . When fed any of the diets, a remarkable reduction of fat mass and adipocyte size was found in our transgenic mice with adipose tissue specific expression of PPARδ. In these transgenic mice, fish oil feeding decreased the adipose tissue expression of the lipogenic genes, LPL, aP2, and SREBP-1c and increased the expression of UCP-3 and the lipolytic gene, HSL. Feeding the PPARδ ligand, L165041 had a similar, but lesser effect than dietary fish oil on these same genes. These results indicate that fish oil treatment increased the function of the overexpressed adipose tissue PPARδ. It has been demonstrated that addition of a PPARδ synthetic ligand, such as GW501516 and L165041, stimulates β-oxidation in fully differentiated adipocytes and that ectopic expression of an activated form of PPARδ in fully differentiated adipocytes promotes glycerol release (Wang et al., 2003) .
Fatty acids are proposed to be possible endogenous ligands for PPARδ based on experiments using transactivation assays or ligand-binding assays (Yu et al., 1995; Forman et al., 1997; Krey et al., 1997) . These studies indicate that PUFA are better activators than SFA. Similar to the effects of a PPARδ synthetic ligand to reduce fat deposition (Wang et al., 2004) , PUFA reduce fat mass by increasing the expression of genes involved in β-oxidation and energy dissipation in the adipose tissue; these genes are regulated by PPARδ (Hun et al., 1999; Holst et al., 2003; Nakatani et al., 2003) . Our findings indicate that PUFA from dietary fish oil elevated genes involved in energy dissipation and decreased lipogenic genes in adipose tissue. The data indicate that PPARδ mediated these effects of fish oil because the effects were so much greater in the transgenic mice overexpressing PPARδ in adipose tissue. The critical difference between previous studies and ours was that we found the effects of fish oil on the adipose tissue to be equal to or greater than feeding transgenic mice a PPARδ synthetic ligand. Our results imply that PUFA or PUFA metabolites are ligands for PPARδ activation and activated PPARδ regulates adipose tissue downstream genes to reduce lipogenic gene expression and increase energy dissipation and lipolysis. The overall result was a reduction in body fat.
Dietary fish oil or DHA is able to reduce plasma triacylglycerol (Liu et al., 2005) and FFA in a dose-dependent fashion (Neschen et al., 2006) . Adipose tissuetargeted expression of a constitutively active form of mouse PPARδ significantly decreases plasma triacylglycerol and FFA (Wang et al., 2003) . Other studies indicate that dietary fish oil reduces plasma triacylglycerol through activation of hepatic PPARα target genes controlling fatty acid oxidation (Wong et al., 1984; Clarke and Jump, 1996) . In the current study, fish oil feeding reduced plasma triacylglycerol and FFA in wild-type mice and further decreased plasma triacylglycerol and FFA in the PPARδ transgenic mice. Similar to the observations on gene expressions in the adipose tissue of fish oil-fed PPARδ transgenic mice, the large improvement in the blood lipid profile was dependent on dietary fish oil plus the overexpressed adipose tissue PPARδ.
Dietary fish oil increases the expression of hepatic β-oxidation genes including ACO and CPT-1 (Clarke and Jump, 1996; Nakatani et al., 2003) . In the current study, we also demonstrated that hepatic β-oxidation genes were stimulated by dietary fish oil in the wildtype mice. In the fish oil-fed PPARδ transgenic mice, the β-oxidation genes including ACO, CPT-1, and LCAD were further upregulated. Therefore, PPARδ not only regulates gene expression in adipose tissue, but it also is directly or indirectly involved in β-oxidation in the liver. Wang et al. (2003) indicated that activated PPARδ in the adipose tissue reduces lipid deposition in the liver when mice are fed with a high-fat diet. Expression of PPARδ is increased after starvation and exercise and functions to increase fatty acid mobilization and oxidation (Holst et al., 2003) . We hypothesize that overexpression of PPARδ in the adipose tissue increases whole body lipid catabolism. In support of this speculation, we provide evidence that the fish-oil fed PPARδ transgenic mice display an increase in expres- sion of genes participating in energy dissipation and lipolysis in the adipose tissue coupled with a remarkable reduction of fat mass. The FFA released from lipolysis may be immediately transported to the liver due to decreased circulating FFA, as observed. Finally, transported FFA are readily oxidized by induced hepatic β-oxidation genes (ACO, CPT-1, and LCAD). In addition to our observations, previous studies partially support our supposition; fish oil increases lipolysis, reduces plasma FFA, and increases hepatic β-oxidation (Clarke and Jump, 1996; Bizeau et al., 2000; Neschen et al., 2006) and PPARδ promotes fatty acid transport and oxidation (Wang et al., 2003) .
In conclusion, we demonstrated that fish oil feeding inhibits adipocyte development and stimulates fatty acid utilization in PPARδ transgenic mice. This transgenic model provided evidence to demonstrate that PUFA, especially EPA and DHA, regulated lipid metabolism through activation of PPARδ to reduce body fat deposition by decreasing lipogenic gene expression and increasing lipolysis and fatty acid oxidation gene expression. These findings indicate that PUFA may serve as effective regulators of lipid catabolism in vivo, and part of the effect is generated through the activation of PPARδ. Therefore, the findings are also valuable for animal production; specifically, the incorporation of some PUFA in the diet may improve the body composition of pigs.
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